Désiré Collen
Honorary Chairman / Board Observer at Fund+
About
MD and PhD chemist from KU Leuven whose team developed t-PA; founder and former chairman of ThromboGenics and recipient of the Francqui Prize.
Honorary Chairman / Board Observer at Fund+
MD and PhD chemist from KU Leuven whose team developed t-PA; founder and former chairman of ThromboGenics and recipient of the Francqui Prize.